Cited by 477Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 149 of the 150 references it cites were found in a registry or an index.

The molecular bases of Alzheimer’s disease and other neurodegenerative disorders

Open access

Maccioni, Ricardo B, Muñoz, Juan P, Barbeito, Luis·2001·Archives of Medical Research

DOI 10.1016/s0188-4409(01)00316-2

Open this paper in CoChat — free account

Abstract

Alzheimer's disease, the cause of one of the most common types of dementia, is a brain disorder affecting the elderly and is characterized by the formation of two main protein aggregates: senile plaques and neurofibrillary tangles, which are involved in the process leading to progressive neuronal degeneration and death. Neurodegeneration in Alzheimer's disease is a pathologic condition of cells rather than an accelerated way of aging. The senile plaques are generated by a deposition in the human brain of fibrils of the beta-amyloid peptide (Abeta), a fragment derived from the proteolytic processing of the amyloid precursor protein (APP). Tau protein is the major component of paired helical filaments (PHFs), which form a compact filamentous network described as neurofibrillary tangles (NFTs). Experiments with hippocampal cells in culture have indicated a relationship between fibrillary amyloid and the cascade of molecular signals that trigger tau hyperphosphorylations. Two main protein kinases have been shown to be involved in anomalous tau phosphorylations: the cyclin-dependent kinase Cdk5 and glycogen synthase kinase GSK3beta. Cdk5 plays a critical role in brain development and is associated with neurogenesis as revealed by studies in brain cells in culture and neuroblastoma cells. Deregulation of this protein kinase as induced by extracellular amyloid loading results in tau hyperphosphorylations, thus triggering a sequence of molecular events that lead to neuronal degeneration. Inhibitors of Cdk5 and GSK3beta and antisense oligonucleotides exert protection against neuronal death. On the other hand, there is cumulative evidence from studies in cultured brain cells and on brains that oxidative stress constitutes a main factor in the modification of normal signaling pathways in neuronal cells, leading to biochemical and structural abnormalities and neurodegeneration as related to the pathogenesis of Alzheimer's disease. This review is focused on the main protein aggregates responsible for neuronal death in both sporadic and familial forms of Alzheimer's disease, as well as on the alterations in the normal signaling pathways of functional neurons directly involved in neurodegeneration. The analysis is extended to the action of neuroprotective factors including selective inhibitors of tau phosphorylating protein kinases, estrogens, and antioxidants among other molecules that apparently prevent neuronal degeneration.

Integrity signals

Registry

Crossref · 10.1016/s0188-4409(01)00316-2

Cites

149 of 149 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy‐Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,715
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436

Show all 150 references

Research works printed but not linked: 2

Catania, 2001, Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells, Neurooncology, 3, 89
Saez, 1990, Gap junctions, In Vitro Toxicol, 3, 69

Sorted by citations

GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Zhao, Y., & Zhao, B. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/316523 · Cited by 855
Expression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760
The dynamic nature of Bruch's membrane
Booij, J. C., Baas, D. C., Beisekeeva, J., Gorgels, T. G. M. F., & Bergen, A. A. B. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.08.003 · Cited by 581
Immunolocalization of peroxisome proliferator-activated receptors and retinoid x receptors in the adult rat CNS
Moreno, S., Vecchioli, S. F., & Cerù, M. P. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.064 · Cited by 595
NOX Enzymes in the Central Nervous System: From Signaling to Disease
Sorce, S., & Krause, K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2578 · Cited by 481
Structure and Pathology of Tau Protein in Alzheimer Disease
Kolarova, M., García‐Sierra, F., Bartoš, A., Říčný, J., & Řípová, D. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/731526 · Cited by 526
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders
Sas, K., Robotka, H., Toldi, J., & Vécsei, L. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.033 · Cited by 465
Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway
Quintanilla, R. A., Orellana, D. I., González-Billault, C., & Maccioni, R. B. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.002 · Cited by 455
Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease
Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf251 · Cited by 454
Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases—A mechanistic approach
Baltazar, M. T., Dinis‐Oliveira, R. J., Bastos, M. D. L., Tsatsakis, A. M., Duarte, J. A., & Carvalho, F. D. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.01.039 · Cited by 410
The genus Polygonatum : A review of ethnopharmacology, phytochemistry and pharmacology
Zhao, P., Zhao, C., Li, X., Gao, Q., Huang, L., Xiao, P., & Gao, W. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.12.006 · Cited by 381
Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
Rojo, L. E., Fernández, J. A., Maccioni, A. A., Jimenez, J. M., & Maccioni, R. B. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.10.001 · Cited by 351
Self-citation
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
Martı́nez, A., Castro, A., Dorronsoro, I., & Alonso, M. (2002) · Medicinal Research Reviews · doi:10.1002/med.10011 · Cited by 335
Insulin in Central Nervous System: More than Just a Peripheral Hormone
Duarte, A. I., Moreira, P. I., & Oliveira, C. R. (2012) · Journal of Aging Research · doi:10.1155/2012/384017 · Cited by 337
The Revitalized Tau Hypothesis on Alzheimer's Disease
Maccioni, R. B., Farias, G. A., Morales, I., & Navarrete, L. P. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.03.007 · Cited by 316
The role of stress in neurodegenerative diseases and mental disorders.
Esch, T., Stefano, G. B., Fricchione, G. L., & Benson, H. (2002) · PubMed · Cited by 306
Nuclear Receptor Coregulators and Human Disease
Lonard, D. M., Lanz, R. B., & O’Malley, B. W. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0012 · Cited by 318
Long Noncoding RNAs: Emerging Stars in Gene Regulation, Epigenetics and Human Disease
Bhan, A., & Mandal, S. S. (2014) · ChemMedChem · doi:10.1002/cmdc.201300534 · Cited by 286
Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease
Ishigami, A., Ohsawa, T., Hiratsuka, M., Taguchi, H., Kobayashi, S., Saito, Y., Murayama, S., Asaga, H., Toda, T., Kimura, N., et al. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20431 · Cited by 277
Epigenetic modification of nucleic acids: from basic studies to medical applications
Chen, Y., Hong, T., Wang, S., Mo, J., Tian, T., & Zhou, X. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00599c · Cited by 277
A Review: The Bioactivities and Pharmacological Applications of Polygonatum sibiricum polysaccharides
Cui, X., Wang, S., Cao, H., Guo, H. W., Li, Y., Xu, F., Zheng, M., Xi, X., & Han, C. (2018) · Molecules · doi:10.3390/molecules23051170 · Cited by 263
The Role of Neuroimmunomodulation in Alzheimer's Disease
Maccioni, R. B., Rojo, L. E., Fernández, J. A., & Kuljiš, R. O. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03972.x · Cited by 261
The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells
Esposito, G., Filippis, D. D., Carnuccio, R., Izzo, A. A., & Iuvone, T. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0025-1 · Cited by 252
Peripheral Oxidative Stress Biomarkers in Mild Cognitive Impairment and Alzheimer's Disease
Torres, L. H., Quaglio, N. B., de Souza, G. T., Garcia, R. C. T., Dati, L. M. M., Moreira, W. L., Loureiro, A. P. D. M., Souza‐Talarico, J. N., Smid, J., Porto, C. S., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110284 · Cited by 239
Ionotropic Glutamate Receptors & CNS Disorders
Bowie, D. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708784083821 · Cited by 207
l-Theanine, an amino acid in green tea, attenuates β-amyloid-induced cognitive dysfunction and neurotoxicity: Reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-κB pathways
Kim, T. I., Lee, Y. K., Park, S. G., Choi, I. S., Ban, J. O., Park, H. K., Nam, S.-Y., Yun, Y. W., Han, S., Oh, K. W., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.09.008 · Cited by 194
Mitochondrial and nuclear DNA-repair capacity of various brain regions in mouse is altered in an age-dependent manner
Imam, S. Z., Karahalıl, B., Hogue, B. A., de Souza-Pinto, N. C., & Bohr, V. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.002 · Cited by 183
Role of Dickkopf-1, an Antagonist of the Wnt/β-Catenin Signaling Pathway, in Estrogen-Induced Neuroprotection and Attenuation of Tau Phosphorylation
Zhang, Q.-G., Wang, R., Khan, M. B., Mahesh, V. B., & Brann, D. W. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2752-08.2008 · Cited by 183
Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress
Poppek, D., Keck, S., Ermak, G., Jung, T., Stolzing, A., Ullrich, O., Davies, K. J. A., & Grune, T. (2006) · Biochemical Journal · doi:10.1042/bj20060463 · Cited by 174
Cu(II) Affinity for the Alzheimer’s Peptide: Tyrosine Fluorescence Studies Revisited
Aliès, B., Renaglia, E., Rózga, M., Bal, W., Faller, P., & Hureau, C. (2012) · Analytical Chemistry · doi:10.1021/ac302629u · Cited by 172
Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00339 · Cited by 170
Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization
Sjöberg, M. K., Shestakova, E., Mansuroglu, Z., Maccioni, R. B., & Bonnefoy, E. (2006) · Journal of Cell Science · doi:10.1242/jcs.02907 · Cited by 166
Self-citation
Tau Oligomers and Fibrils Induce Activation of Microglial Cells
Morales, I., Jiménez, J. M., Mancilla, M., & Maccioni, R. B. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-131843 · Cited by 160
The Effectiveness of Vitamin E Treatment in Alzheimer’s Disease
Lloret, A., Esteve, D., Monllor, P., Cervera‐Ferri, A., & Lloret, Á. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040879 · Cited by 165
Oxidative stress and its association with coronary artery disease and different atherogenic risk factors
Vassalle, C., Petrozzi, L., Botto, N., Andreassi, M. G., & Zucchelli, G. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01373.x · Cited by 156
Exploring the Secrets of Long Noncoding RNAs
Quan, M., Chen, J., & Zhang, D. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16035467 · Cited by 148
Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-β peptides involved in Alzheimer disease. Part 2: Dependence of Cu(II) binding sites with Aβ sequences
Hureau, C., & Dorlet, P. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.034 · Cited by 148
Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein
Wen, Y., Yang, S., Liu, R., & Simpkins, J. W. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.106 · Cited by 147
Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease
González‐Domínguez, R., García‐Barrera, T., & Gómez‐Ariza, J. L. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.01.014 · Cited by 144
Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system
Zhong, Z., Han, J., Zhang, J., Xiao, Q., Hu, J., & Chen, L. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s160776 · Cited by 141
Selective Interaction of Lansoprazole and Astemizole with Tau Polymers: Potential New Clinical Use in Diagnosis of Alzheimer's Disease
Rojo, L. E., Alzate‐Morales, J. H., Saavedra, I. N., Davies, P., & Maccioni, R. B. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1262 · Cited by 141
A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?
Francis, P. T., Nordberg, A. K., & Arnold, S. E. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.010 · Cited by 144
Role of Cell Cycle Re-Entry in Neurons: A Common Apoptotic Mechanism of Neuronal Cell Death
Folch, J., Junyent, F., Verdaguer, E., Auladell, C., Pizarro, J. G., Beas‐Zárate, C., Pallàs, M., & Camins, A. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9277-4 · Cited by 144
Effect of aged garlic extract on APP processing and tau phosphorylation in Alzheimer's transgenic model Tg2576
Chauhan, N. B. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.05.030 · Cited by 138
Drug development for alzheimer’s disease: Microglia induced neuroinflammation as a target
Dong, Y., Li, X., Cheng, J., & Hou, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030558 · Cited by 136
Involvement of Calpain Activation in Neurodegenerative Processes
Camins, A., Verdaguer, E., Folch, J., & Pallàs, M. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00135.x · Cited by 134
Alzheimer disease and platelets: how’s that relevant
Catricalà, S., Torti, M., & Ricevuti, G. (2012) · Immunity & Ageing · doi:10.1186/1742-4933-9-20 · Cited by 132
Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease
Kawamoto, E. M., Munhoz, C. D., Glezer, I., Bahia, V. S., Caramelli, P., Nitríni, R., Gorjão, R., Curi, R., Scavone, C., & Marcourakis, T. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.011 · Cited by 129
Divergent roles of GSK3 and CDK5 in APP processing
Ryder, J. W., Yuan, S., Liu, F., Li, B., Zhou, Y., & Ni, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.014 · Cited by 126
Cognitive aging is linked to social role in honey bees (Apis mellifera)
Behrends, A., Scheiner, R., BAKER, N., & Amdam, G. V. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.09.003 · Cited by 127
Antioxidant Treatment in Alzheimer's Disease: Current State
Gilgun‐Sherki, Y., Melamed, E., & Offen, D. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:21:1:1 · Cited by 126
Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation
Sharifi-Rad, J., Rapposelli, S., Sestito, S., Herrera-Bravo, J., Arancibia-Diaz, A., Salazar, L. A., Yeskaliyeva, B., Beyatli, A., Leyva-Gómez, G., González-Contreras, C., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091515 · Cited by 125
“The tau protein is a filamentous protein associated with microtubules; in healthy neuronal cells, following consecutive and reversible enzymatic processes of phosphorylation and dephosphorylation, it has the task of assembling and stabilizing microtubules and determining their binding with other components of the cyto…”
Background
AβPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576
Carola Otth, L., Concha, I. I., Arendt, T., Stieler, J., Schliebs, R., González-Billault, C. E., & Maccioni, R. B. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4508 · Cited by 119
Recent rodent models for Alzheimer’s disease: clinical implications and basic research
Braidy, N., Muñoz, P., Palacios, A. G., Castellano‐González, G., Inestrosa, N. C., Chung, R. S., Sachdev, P. S., & Guillemin, G. J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0731-5 · Cited by 126
Characterization of metal profiles in serum during the progression of Alzheimer's disease
González‐Domínguez, R., García‐Barrera, T., & Gómez‐Ariza, J. L. (2013) · Metallomics · doi:10.1039/c3mt00301a · Cited by 119
Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease
Vassalle, C., Botto, N., Andreassi, M. G., Berti, S. L., & Biagini, A. (2003) · Coronary Artery Disease · doi:10.1097/01.mca.0000063504.13456.c3 · Cited by 117
Expanded-Polyglutamine Huntingtin Protein Suppresses the Secretion and Production of a Chemokine (CCL5/RANTES) by Astrocytes
Chou, S., Weng, J.-Y., Lai, H., Liao, F., Sun, S. H., Tu, P., Dickson, D. W., & Chern, Y. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0116-08.2008 · Cited by 115
Estrogen Induces Estrogen Receptor α-Dependent cAMP Response Element-Binding Protein Phosphorylation via Mitogen Activated Protein Kinase Pathway in Basal Forebrain Cholinergic NeuronsIn Vivo
Szegő, É. M., Barabás, K., Balog, J., Szilágyi, N., Korach, K. S., Juhász, G. D., & Ábrahám, I. M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0222-06.2006 · Cited by 117
Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures
Egaña, J. T., Zambrano, C. A., Núñez, M. T., González-Billault, C. E., & Maccioni, R. B. (2003) · BioMetals · doi:10.1023/a:1020727218493 · Cited by 114
Supplementation of Convolvulus pluricaulis attenuates scopolamine-induced increased tau and Amyloid precursor protein (AβPP) expression in rat brain
Bihaqi, S. W., Singh, A., & Tiwari, M. (2012) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.100383 · Cited by 108
Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation
Guix, F. X., ILL‐Raga, G., Bravo, R., Nakaya, T., Fabritiis, G. D., Coma, M., Miscione, G. P., Villà-Freixa, J., Suzuki, T., Fernàndez‐Busquets, X., et al. (2009) · Brain · doi:10.1093/brain/awp023 · Cited by 107
Non-invasive brain stimulation to assess and modulate neuroplasticity in Alzheimer's disease
Boggio, P. S., Valasek, C. A., Campanhã, C., Giglio, A. C. A., Baptista, N. I., Lapenta, O. M., & Fregni, F. (2011) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2011.617943 · Cited by 111
Beyond Erectile Dysfunction: cGMP-Specific Phosphodiesterase 5 Inhibitors for Other Clinical Disorders
Samidurai, A., Xi, L., Das, A., & Kukreja, R. C. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-040122-034745 · Cited by 114
GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer’s disease
Nava-Mesa, M. O., Jiménez‐Díaz, L., Yajeya, J., & Navarro‐López, J. D. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00167 · Cited by 106
Alzheimer’s Disease and Cancer: When Two Monsters Cannot Be Together
Majd, S., Power, J., & Majd, Z. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00155 · Cited by 102
Effects of rosmarinic acid on nervous system disorders: an updated review
Rahbardar, M. G., & Hosseinzadeh, H. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01935-w · Cited by 107
Post-mortem Interval Effects on the Phosphorylation of Signaling Proteins
Li, J., Gould, T. D., Yuan, P., Manji, H. K., & Chen, G. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300112 · Cited by 105
Caffeoylquinic Acids in Centella asiatica Protect against Amyloid-β Toxicity
Gray, N. E., Morré, J., Kelley, J., Maier, C. S., Stevens, J. F., Quinn, J. F., & Soumyanath, A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131913 · Cited by 101
Homeostasis of metals in the progression of Alzheimer’s disease
González‐Domínguez, R., García‐Barrera, T., & Gómez‐Ariza, J. L. (2014) · BioMetals · doi:10.1007/s10534-014-9728-5 · Cited by 101
Comparison of biochemical effects of statins and fish oil in brain: The battle of the titans
Farooqui, A. A., Ong, W., Horrocks, L. A., Chen, P., & Farooqui, T. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.004 · Cited by 100
Rapid Tau Aggregation and Delayed Hippocampal Neuronal Death Induced by Persistent Thrombin Signaling
Suo, Z., Wu, M., Citron, B. A., Palazzo, R. E., & Festoff, B. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301406200 · Cited by 99
Temperature-Sensitive Paralytic Mutants Are Enriched For Those Causing Neurodegeneration in Drosophila
Palladino, M. J., Hadley, T. J., & Ganetzky, B. (2002) · Genetics · doi:10.1093/genetics/161.3.1197 · Cited by 98
Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease
González‐Domínguez, R., García‐Barrera, T., Vitórica, J., & Gómez‐Ariza, J. L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.014 · Cited by 97
Direct Infusion Mass Spectrometry for Metabolomic Phenotyping of Diseases
González‐Domínguez, R., Sayago, A., & Fernández‐Recamales, Á. (2016) · Bioanalysis · doi:10.4155/bio-2016-0202 · Cited by 100
Human Platelets Tau: A Potential Peripheral Marker for Alzheimer's Disease
Neumann, K., Farias, G. A., Slachevsky, A., Perez, P., & Maccioni, R. B. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101641 · Cited by 95
Apoptotic mechanisms involved in neurodegenerative diseases: Experimental and therapeutic approaches
Camins, A., Pallàs, M., & Silvestre, J. S. (2008) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2008.30.1.1090962 · Cited by 95
Aging and Neutrophils: There Is Still Much To Do
Fortin, C. F., McDonald, P. P., Lesur, O., & Fülöp, T. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0750 · Cited by 97
Age-dependent change of HMGB1 and DNA double-strand break accumulation in mouse brain
Enokido, Y., Yoshitake, A., Ito, H., & Okazawa, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.108 · Cited by 96
Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer’s disease
Zuccarello, E., Acquarone, E., Calcagno, E., Argyrousi, E. K., Deng, S., Landry, D. W., Arancio, O., & Fiorito, J. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113818 · Cited by 93
The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer’s Disease
Calfío, C., González, A., Singh, S. K., Rojo, L. E., & Maccioni, R. B. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200443 · Cited by 95
RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer’s disease
Wong, H., Levenga, J., Cain, P., Rothermel, B. A., Klann, E., & Hoeffer, C. A. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1499-8 · Cited by 91
Fulvic Acid Inhibits Aggregation and Promotes Disassembly of Tau Fibrils Associated with Alzheimer's Disease
Cornejo, A., Jiménez, J. M., Caballero, L., Melo, F., & Maccioni, R. B. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110623 · Cited by 89
Tenuigenin treatment decreases secretion of the Alzheimer’s disease amyloid β-protein in cultured cells
Jia, H., Jiang, Y., Ruan, Y., Zhang, Y., Ma, X., Zhang, J., Beyreuther, K. T., Tu, P., & Zhang, D. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.093 · Cited by 88
Impaired spatial working memory and altered choline acetyltransferase (CHAT) immunoreactivity and nicotinic receptor binding in rats exposed to intermittent hypoxia during sleep
Row, B. W., Kheirandish, L., Cheng, Y.-S., Rowell, P. P., & Gozal, D. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.11.028 · Cited by 86
Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease
Бачурин, С. О. (2002) · Medicinal Research Reviews · doi:10.1002/med.10026 · Cited by 91
Drosophila long-term memory formation involves regulation of cathepsin activity
Comas, D., Petit, F., & Préat, T. (2004) · Nature · doi:10.1038/nature02726 · Cited by 86
Accumulation of nuclear DNA damage or neuron loss: Molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases
Brasnjevic, I., Hof, P. R., Steinbusch, H. W. M., & Schmitz, C. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.03.010 · Cited by 90
Oxidative stress promotes $tau; dephosphorylation in neuronal cells: the roles of cdk5 and PP1
Zambrano, C. A., Egaña, J. T., Núñez, M. T., Maccioni, R. B., & González-Billault, C. E. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.03.007 · Cited by 90
Cdk5: mediator of neuronal death and survival
Cheung, Z. H., & Ip, N. Y. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.12.117 · Cited by 85
Schisandrin B Ameliorates ICV-Infused Amyloid β Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression
Giridharan, V. V., Thandavarayan, R. A., Arumugam, S., Mizuno, M., Nawa, H., Suzuki, K., Ko, K. M., Krishnamurthy, P., Watanabe, K., & Konishi, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142483 · Cited by 84
Changes in oxidative stress parameters and neurodegeneration markers in the brain of the senescence-accelerated mice SAMP-8
Sureda, F. X., Cuesta, J., Romeu, M., Mulero, M., Canudas, A. M., Camins, A., Mallol, J., & Pallàs, M. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.01.015 · Cited by 84
CDK5: A Unique CDK and Its Multiple Roles in the Nervous System
Cortés, N., Guzmán‐Martínez, L., Andrade, V., González, A., & Maccioni, R. B. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180792 · Cited by 82
Physiological Roles of Glycogen Synthase Kinase-3: Potential as a Therapeutic Target for Diabetes and Other Disorders
Woodgett, J. R. (2003) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008033340153 · Cited by 82
Biomarkers for Alzheimer’s Disease
Guzman-Martinez, L., Maccioni, R. B., Farías, G. A., Fuentes, P., & Navarrete, L. P. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190517121140 · Cited by 87
pH-Dependent Cu(II) Coordination to Amyloid-β Peptide: Impact of Sequence Alterations, Including the H6R and D7N Familial Mutations.
Aliès, B., Eury, H., Bijani, C., Rechignat, L., Faller, P., & Hureau, C. (2011) · Inorganic Chemistry · doi:10.1021/ic201739n · Cited by 80
Olive Oil Phenols as Promising Multi-targeting Agents Against Alzheimer’s Disease
Rigacci, S. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-18365-7_1 · Cited by 84
Calcineurin dephosphorylates glycogen synthase kinase‐3 beta at serine‐9 in neuroblast‐derived cells
Kim, Y., Lee, Y., Seo, M., Kim, S., Lee, J., Youn, H., Kim, Y. S., & Juhnn, Y. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06318.x · Cited by 80
Effect of Boswellia serrata on Alzheimer′s disease induced in rats
Yassin, N., El-Shenawy, S. M. A., Mahdy, K., Gouda, N. A., Marrie, A. E.-F. H., Farrag, A. R., & Ibrahim, B. M. M. (2013) · Journal of The Arab Society for Medical Research · doi:10.4103/1687-4293.132766 · Cited by 77
Salidroside - Can it be a Multifunctional Drug?
Magani, S. K. J., Mupparthi, S. D., Gollapalli, B. P., Shukla, D., Tiwari, A. K., Gorantala, J., Yarla, N. S., & Tantravahi, S. (2020) · Current Drug Metabolism · doi:10.2174/1389200221666200610172105 · Cited by 76

Authors: Maccioni, R. B., Muñoz, J. P., & Barbeito, L.
Affiliations: University of Chile (CL)
Instituto de Investigaciones Biológicas Clemente Estable (UY)
Corresponding author: Maccioni, Ricardo B
ORCID: Maccioni, Ricardo B
Muñoz, Juan P
Barbeito, Luis
Venue: Archives of Medical Research
Publisher: Elsevier BV
Published: 2001-09
Volume: 32
Issue: 5
Pages: 367-381
ISSN: 0066-6769 (ISSN-L)
0188-4409
DOI: 10.1016/s0188-4409(01)00316-2
OpenAlex: W1985122965
Cited by: 474
References: 150
Citations by year: 2026: 8 · 2025: 12 · 2024: 24 · 2023: 8 · 2022: 13 · 2021: 14 · 2020: 17 · 2019: 19 · 2018: 20 · 2017: 28 · 2016: 17 · 2015: 17 · 2014: 19 · 2013: 22 · 2012: 30
FWCI: 2.49
Type: journal article
Language: en
Open access: green
americanae.aecid.es
Licence: other-oa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Archives of Medical Research (publishedVersion)
PubMed (publishedVersion)
Americanae (AECID Library) (submittedVersion, other-oa)
LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, neurodegeneration, amyloid plaques, neurofibrillary tangles, amyloid-beta, amyloid precursor protein, tau protein, tau hyperphosphorylation, cyclin-dependent kinase 5, GSK3β, oxidative stress, neuronal cell death, neuroprotective factors, estrogen, antioxidants, protein kinase inhibitors, antisense oligonucleotides, dementia
MeSH terms: Adult, Aged, alpha-Macroglobulins, Alzheimer Disease, Amino Acid Sequence, Apolipoproteins E, Astrocytes, Calcium, Estrogens, Humans, Membrane Proteins, Memory Disorders, Middle Aged, Molecular Sequence Data, Nerve Tissue Proteins, Neurons, Neurotoxins, Nitric Oxide, Parkinson Disease, Protein Processing, Post-Translational, Signal Transduction, Motor Neuron Disease, Amyloid beta-Protein Precursor, Neurofibrillary Tangles, tau Proteins, Cell Death, Age of Onset, Oxidative Stress, Neurodegenerative Diseases, Caspases, Presenilin-1, Presenilin-2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The molecular bases of Alzheimer’s disease and other neurodegenerative disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks